Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

NCT07734649 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

2400

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Immunization
Human Metapneumovirus Immunization
Healthy Volunteers

Interventions

BIOLOGICAL: RSV+HMPV vaccine
BIOLOGICAL: Control Vaccine 3
BIOLOGICAL: Control Vaccine 4
BIOLOGICAL: Control Vaccine 2
OTHER: Placebo
BIOLOGICAL: Control Vaccine 1

Sponsor

Sanofi